Trade GlaxoSmithKline PLC - GSKl CFD

Add to favourite

14.400

0.48%

0.040

Low: 14.38

High: 14.65

Market Trading Hours* (UTC) Opens on Wednesday at 08:00

Mon - Fri: 08:00 - 12:00 12:03 - 16:30

Summary
Historical Data

Trading сonditions

Spread

0.040

Long position overnight fee

-0.023251%

Short position overnight fee

0.001333%

Overnight fee time

22:00 (UTC)

Min traded quantity

Currency

GBP

Margin

5.00%

Stock exchange

United Kingdom of Great Britain and Northern Ireland

Commission on trade

Key Stats

Prev. Close	14.47
Open	14.65
1-Year Change	-11.45%
Day's Range	14.38 - 14.65

Last Week
Last Month
Last Year
Last two Years
Max

Daily
Weekly
Monthly

Date	Close	Change	Change (%)	Open	High	Low
Feb 10, 2025	14.470	0.115	0.80%	14.355	14.770	14.355
Feb 7, 2025	14.385	-0.025	-0.17%	14.410	14.570	14.335
Feb 6, 2025	14.745	0.060	0.41%	14.685	15.015	14.560
Feb 5, 2025	14.540	0.240	1.68%	14.300	14.885	14.225
Feb 4, 2025	13.730	-0.130	-0.94%	13.860	13.985	13.555
Feb 3, 2025	13.935	-0.030	-0.21%	13.965	14.035	13.795
Jan 31, 2025	14.035	0.070	0.50%	13.965	14.085	13.965
Jan 30, 2025	13.970	0.080	0.58%	13.890	13.985	13.660
Jan 29, 2025	13.695	-0.155	-1.12%	13.850	14.010	13.695
Jan 28, 2025	13.885	-0.115	-0.82%	14.000	14.140	13.760
Jan 27, 2025	14.000	0.440	3.24%	13.560	14.015	13.560
Jan 24, 2025	13.545	-0.085	-0.62%	13.630	13.685	13.395
Jan 23, 2025	13.385	0.000	0.00%	13.385	13.660	13.385
Jan 22, 2025	13.510	-0.060	-0.44%	13.570	13.605	13.440
Jan 21, 2025	13.480	-0.045	-0.33%	13.525	13.610	13.455
Jan 20, 2025	13.490	-0.055	-0.41%	13.545	13.630	13.350
Jan 17, 2025	13.545	-0.100	-0.73%	13.645	13.720	13.505
Jan 16, 2025	13.465	0.155	1.16%	13.310	13.470	13.265
Jan 15, 2025	13.040	0.030	0.23%	13.010	13.260	12.985
Jan 14, 2025	12.915	-0.365	-2.75%	13.280	13.285	12.830

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission

1:1
2:1
3:1
5:1
10:1
20:1

Leverage

20:1

20
100
500
1000
10000

Investment

Trade size (Leverage x Investement):

Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

GSK Company profile

GlaxoSmithKline PLC - GSK CFD

GlaxoSmithKline (GSK) is a global healthcare company focussed in pharmaceuticals, vaccine development and consumer healthcare products.

The company began as an apothecary shop in London in 1715. Today, GlaxoSmithKline is headquartered in Brentford, England, with regional offices in the US and Singapore. GlaxoSmithKline’s primary listing is on the London Stock Exchange under the ticker symbol ‘GSK’. The GSK stock price in the form of American depositary shares is listed on the New York Stock Exchange.

GlaxoSmithKline’s pharmaceutical business covers a broad portfolio of medicines in respiratory, HIV, immuno-inflammation and oncology. The company has a leadership position in respiratory disease medicines. GlaxoSmithKline’s HIV business is managed through its unit ViiV Healthcare, with Pfizer and Shionogi as minority shareholders.

In addition to respiratory and HIV treatments, the company has a portfolio of pharmaceutical products for the treatment of conditions such as lupus, urology and anti-infectives.

Its Established Products Portfolio (EPP) includes mature medicines in the areas of anti-infectives, allergy, central nervous system, dermatology, respiratory and urology. These products are an important part of our Emerging Markets business.

GlaxoSmithKline is actively researching the World Health Organisation’s three priority diseases - HIV/AIDS, tuberculosis and malaria.

GlaxoSmithKline is also one of the world’s largest vaccine companies with a portfolio of more than 20 vaccines. The company has 12 vaccine manufacturing sites around the world. One of its four global R&D centres is dedicated to mRNA technology.

GlaxoSmithKline’s consumer healthcare business has portfolio of brands that include Sensodyne, Parodontax, Polident, Advil, Voltaire, Panadol, Striven, Theraflu and Centrum across oral health, pain relief, cold, flu and allergy, digestive health, and vitamins, mineral and supplements segments. GlaxoSmithKline is set to spin-off its consumer healthcare business into an independent company under the name ‘Haleon’.’

The company pays dividends on a quarterly basis, in July, October, January and April.
Follow the GlaxoSmithKline stock price live at Capital.com today.

Industry:

Pharmaceuticals (NEC)

980 Great West Road
BRENTFORD
MIDDLESEX TW8 9GS
GB

News

Microsoft Stock Price Forecast for 2025 and beyond: Third party price target

We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...

18:29, 7 February 2025

Ripple XRP price prediction: Third-party price target

Discover the ripple (XRP) price predictions for 2025 and beyond, with analyst price targets and CFDs trading strategies on Capital.com

15:29, 6 February 2025

Apple Store on Fifth Avenue, New York, October 2016

Apple (AAPL) stock price forecast: third-party price target

We looked at the forecasts for Apple stock in 10 years to see where the price would likely be at that point and the challenges the company could face. Read more.

11:22, 6 February 2025